(Q84735057)
Statements
Final overall survival results and effect of prolonged (≥ 1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial (English)
Ian Smith
Jean-Yves Pierga
Hernan Cortes-Funes
Christoph Thomssen
Silvana Saracchini
Bella Nisenbaum
Ignacio Pelaez
Anja-Alexandra Duenne
Kathleen I Pritchard